18F-FDG PET/CT imaging in oncology.
18F-FDG PET/CT imaging in oncology.
复制标题
DOI:
10.4103/0256-4947.75771
复制
发表时间:
2011-01
影响因子:
1.6
通讯作者:
Bomanji J
中科院分区:
文献类型:
--
作者:
Almuhaideb A;Papathanasiou N;Bomanji J
Accurate diagnosis and staging are essential for the optimal management of cancer patients. Positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) has emerged as a powerful imaging tool for the detection of various cancers. The combined acquisition of PET and CT has synergistic advantages over PET or CT alone and minimizes their individual limitations. It is a valuable tool for staging and restaging of some tumors and has an important role in the detection of recurrence in asymptomatic patients with rising tumor marker levels and patients with negative or equivocal findings on conventional imaging techniques. It also allows for monitoring response to therapy and permitting timely modification of therapeutic regimens. In about 27% of the patients, the course of managment is changed. This review provides guidance for oncologists/ radiotherapists and clinical and surgical specialists on the use of 18F-FDG PET/CT in oncology.
登录
查看更多内容
DOI:
10.1102/1470-7330.2006.9014
发表时间:
2006-10-31
期刊:
Cancer imaging : the official publication of the International Cancer Imaging Society
影响因子:
--
作者:
de Geus-Oei, Lioe-Fee;Ruers, Theo J M;Oyen, Wim J G
通讯作者:
Oyen, Wim J G
影响因子:
158.5
作者:
Bernier, J;Domenge, C;van Glabbeke, M
通讯作者:
van Glabbeke, M
DOI:
10.1016/j.ijrobp.2006.03.015
发表时间:
2006-08-01
影响因子:
7
作者:
Andrade, Regiane S.;Heron, Dwight E.;Avril, Norbert
通讯作者:
Avril, Norbert
影响因子:
9.6
作者:
Bastiaannet, E;Oyen, WJG;Hoekstra, HJ
通讯作者:
Hoekstra, HJ
影响因子:
4.6
作者:
Cerfolio, RJ;Bryant, AS;Bartolucci, AA
通讯作者:
Bartolucci, AA